Monopar Therapeutics is handing over cash and equity to AstraZeneca to further develop a treatment for Wilson disease that ...

Q3 2024 - Financial highlights•Net revenue was SEK 239.6 (236.4) million, corresponding to a rise of 1.4% (-16.9%)•Gross profit was SEK 130.7 (119.8) million, corresponding to a gross margin of 54.5% ...

Gaming operator the Kindred Group has published its results for Q3, hailing a “strong performance” across its key markets and ...

JANUARY - SEPTEMBER 2024 Rental revenue increased 16% to SEK 3,678 M (SEK 3,160 M in the year-earlier period). Profit from property management attributable to the Parent Company's shareholders increas ...

This information is information that Akelius Residential Property AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 09.30am ...

SUSTAINED STRONG ORDER INTAKE AND CASH FLOW IMPROVEMENT Financial development third quarter 2024 Net sales increased by 10.3% to SEK 250 million (226). The gross margin was 50.0% (50.0). Adjusted ...

Another quarter in line with previous yearWe have increased sales for the third quarter by 4 percent to SEK 1,917 (1,847) million. In the same period, EBITA has fallen slightly to SEK 186 (192) millio ...

Strong organic growth and increased profitability July - September 2024 Revenues increased by 6.3 per cent to SEK 1,132.5 million (1,065.3). Adjusted EBITA increased by 8.9 per cent and amounted ...

"Under the period January-September net operating income totalled SEK 5,134 M, corresponding to an increase of 3.9 per cent. With a strong financial position, a robust cash flow and a good financing m ...

Organic growth despite economic slowdown in Europe Net revenue totaled MSEK 1,683 (1,676)Adjusted operating profit (EBIT) amounted to MSEK 212 (225), corresponding to an operating margin of 12.6 perce ...